Northern-southern route to synthesis of bacteriochlorins

1. A method of making a compound of Formula I:

or a metal conjugate thereof, wherein:

each R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, a hydrophilic group, a linking group, a surface attachment group, and a targeting group, wherein the hydrophilic group is selected from the group consisting of a polyol, polyalkylene oxide group, ionic group, polar group, and any combination thereof, wherein the linking group is selected from the group consisting of aryl, alkyl, heteroaryl, heteroalkyl, a peptide, a polysaccharide, and any combination thereof, and wherein the targeting group is selected from the group consisting of an antibody, a ligand, one member of a ligand-receptor binding pair, a nucleic acid, a protein, a liposomal suspension, and any combination thereof;

or R 1 and R 2 together are ═O or spiroalkyl;

or R 3 and R 4 together are ═O or spiroalkyl;

where R 6 and R 7 , or R 7 and R 8 , together represent a fused aromatic or heteroaromatic ring systems;

said method comprising condensing a pair of compounds of Formula II:

in an organic solvent in the presence of an acid,

where each R′ independently represents C1-C4 alkyl, or both R′ together represent C2-C4 alkylene; to produce a compound of Formula I wherein R 5 is H or alkoxy,

wherein condensing the pair of compounds of Formula II comprises performing two successive Pd-coupling reactions.

2. The method of claim 1 , wherein said compound of Formula I has the structure of Formula IA or Formula IB:

or a metal conjugate thereof, wherein:

rings A and B represent a fused aromatic or heteroaromatic ring system;

n is from 1 or 2 to 4, 6 or 8; and

each R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 8 and R 11 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, hydrophilic groups, linking groups, surface attachment groups, and targeting groups;

or R 1 and R 2 together are ═O or spiroalkyl;

or R 3 and R 4 together are ═O or spiroalkyl.

3. The method of claim 2 , wherein said compound of Formula II has the structure:

4. The method of claim 3 , wherein said compound of Formula I has a structure selected from the group consisting of:

where:

n is from 1 or 2 to 4, 6 or 8;

each R 11 , which may be substituted on any member ring of the corresponding ring system (A or B), is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, hydrophilic groups, linking groups, surface attachment groups, and targeting groups; and

each R 12 of Formula IBvii or IBviii is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, hydrophilic groups, linking groups, surface attachment groups, and targeting groups.

5. The method of claim 1 , wherein said compound is a conjugate with a metal selected from the group consisting of Pd, Pt, Mg, Zn, Al, Ga, In, Sn, Cu, Ni, and Au.

6. The method of claim 1 , wherein said compound of Formula II has a structure selected from the group consisting of:

7. The method of claim 1 , wherein:

at least one of R 1 through R 12 comprises a linking group, a hydrophilic group, and/or a targeting group.

8. The method of claim 1 , wherein:

each R 1 comprises a hydrophilic group, and each R 2 , R 3 , and/or R 4 comprises a linking group or targeting group; or

each R 2 comprises a hydrophilic group, and each R 1 , R 3 , and/or R 4 comprises a linking group or targeting group; or

each R 3 comprises a hydrophilic group, and each R 1 , R 2 , and/or R 4 comprises a linking group or targeting group; or

each R 4 comprises a hydrophilic group, and each R 1 , R 2 , and/or R 3 comprises a linking group or targeting group.

9. The method of claim 1 , wherein the two successive Pd-coupling reactions comprise reacting a 3,13-dibromo-8,8,18,18-tetramethylbacteriochlorin with about two equivalents of an arene bearing adjacent halo and dihydroxyboryl or dialkoxyboryl groups, and performing a ring closure to provide a beta-meso-annulated bacteriochlorin.

10. The method of claim 1 , further comprising performing a Suzuki coupling reaction.

11. A compound of Formula IA or Formula IB:

or a metal conjugate thereof, wherein:

rings A and B represent a fused aromatic or heteroaromatic ring system;

n is from 1 or 2 to 4, 6, or 8; and

each R 2 , R 3 , R 4 , R 5 , R 6 , R 8 and R 11 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, a hydrophilic group, a linking group, a surface attachment group, and a targeting group, wherein the hydrophilic group is selected from the group consisting of a polyol, polyalkylene oxide group, ionic group, polar group, and any combination thereof, wherein the linking group is selected from the group consisting of aryl, alkyl, heteroaryl, heteroalkyl, a peptide, a polysaccharide, and any combination thereof, and wherein the targeting group is selected from the group consisting of an antibody, a ligand, one member of a ligand-receptor binding pair, a nucleic acid, a protein, a peptide, a liposomal suspension, and any combination thereof;

or R 1 and R 2 together are ═O or spiroalkyl;

or R 3 and R 4 together are ═O or spiroalkyl, and

wherein:

each R 1 comprises a hydrophilic group, and each R 2 , R 3 , and/or R 4 comprises a linking group or targeting group; or

each R 2 comprises a hydrophilic group, and each R 1 , R 3 , and/or R 4 comprises a linking group or targeting group; or

each R 3 comprises a hydrophilic group, and each R 1 , R 2 , and/or R 4 comprises a linking group or targeting group; or

each R 4 comprises a hydrophilic group, and each R 1 , R 2 , and/or R 3 comprises a linking group or targeting group.

12. The compound of claim 11 selected from the group consisting of:

where:

n is from 1 or 2 to 4, 6 or 8;

each R 11 , which may be substituted on any member ring of the corresponding ring system (A or B), is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, hydrophilic groups, linking groups, surface attachment groups, and targeting groups; and

each R 12 of Formula IBvii or IBviii is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, hydrophilic groups, linking groups, surface attachment groups, and targeting groups.

13. The compound of claim 11 , wherein said compound is a conjugate with a metal selected from the group consisting of Pd, Pt, Mg, Zn, Al, Ga, In, Sn, Cu, Ni, and Au.

14. A method for treating a target in a subject in need thereof, comprising: (i) administering to said subject the compound of claim 11 or a pharmaceutically acceptable conjugate thereof that preferentially associates with the target, and (ii) irradiating the target with light of a wavelength and intensity sufficient to treat said target.

15. A photodynamic therapy method for treating hyperproliferative tissue in a subject in need thereof, comprising: (i) administering to said subject a compound of claim 11 or a pharmaceutically acceptable conjugate thereof that preferentially associates with the hyperproliferative tissue, and (ii) irradiating the target with light of a wavelength and intensity sufficient to activate the compound, and thereby treat said hyperproliferative tissue.

16. A method for detecting the presence of a hyperproliferative tissue in a subject, comprising: (i) administering to the subject a compound of claim 11 or a pharmaceutically acceptable conjugate thereof that preferentially associates with the hyperproliferative tissue; and then (ii) visualizing the compound within the patient.

17. A method of detecting cells or particles by flow cytometry, comprising utilizing a compound of claim 11 as a detectable compound, wherein said cells or particles are labelled with the detectable compound.

18. A method of making a compound of Formula I:

or a metal conjugate thereof, wherein:

each R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, a hydrophilic group, a linking group, a surface attachment group, and a targeting group, wherein the hydrophilic group is selected from the group consisting of a polyol, polyalkylene oxide group, ionic group, polar group, and any combination thereof, wherein the linking group is selected from the group consisting of aryl, alkyl, heteroaryl, heteroalkyl, a peptide, a polysaccharide, and any combination thereof, and wherein the targeting group is selected from the group consisting of an antibody, a ligand, one member of a ligand-receptor binding pair, a nucleic acid, a protein, a peptide, a liposomal suspension, and any combination thereof;

or R 1 and R 2 together are ═O or spiroalkyl;

or R 3 and R 4 together are ═O or spiroalkyl;

where R 6 and R 7 , or R 7 and R 8 , together represent a fused aromatic or heteroaromatic ring systems;

said method comprising condensing a pair of compounds of Formula II:

in an organic solvent in the presence of an acid,

where each R′ independently represents C1-C4 alkyl, or both R′ together represent C2-C4 alkylene; to produce a compound of Formula I wherein R 5 is H or alkoxy,

wherein said compound of Formula II has a structure selected from the group consisting of: